AxTalis news and insights

The MAP Group Unites Three Companies Under One New Brand Name, KINTIGA™

As we reflect on Tuesday’s seventh and final regional meeting
We meet with Domien Verdonck, Regulatory and Pharmacovigilance Officer, who
2025 will mark the 20th anniversary of the Small and
Join Sven and Maud at a webinar about EU HTA
Last week, our team gathered in London for our Spring
MAP Patient Access and AxTalis join forces to create a